Wealthfront Advisers’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.52M Buy
13,630
+4,250
+45% +$1.1M 0.01% 445
2025
Q1
$2.1M Buy
9,380
+1,338
+17% +$300K 0.01% 525
2024
Q4
$1.84M Buy
8,042
+224
+3% +$51.2K 0.01% 541
2024
Q3
$1.91M Buy
7,818
+734
+10% +$179K 0.01% 510
2024
Q2
$1.36M Sell
7,084
-186
-3% -$35.6K ﹤0.01% 567
2024
Q1
$1.44M Buy
7,270
+15
+0.2% +$2.97K 0.01% 546
2023
Q4
$1.25M Buy
7,255
+2,583
+55% +$444K ﹤0.01% 555
2023
Q3
$691K Sell
4,672
-4,376
-48% -$647K ﹤0.01% 625
2023
Q2
$1.98M Sell
9,048
-794
-8% -$173K 0.01% 416
2023
Q1
$2.16M Buy
9,842
+257
+3% +$56.3K 0.01% 395
2022
Q4
$1.99M Sell
9,585
-1,314
-12% -$273K 0.01% 405
2022
Q3
$2.38M Buy
10,899
+515
+5% +$112K 0.01% 328
2022
Q2
$2.18M Buy
10,384
+2,217
+27% +$465K 0.01% 358
2022
Q1
$1.98M Sell
8,167
-271
-3% -$65.7K 0.01% 399
2021
Q4
$2.2M Sell
8,438
-402
-5% -$105K 0.01% 361
2021
Q3
$2.33M Buy
8,840
+862
+11% +$227K 0.01% 316
2021
Q2
$1.97M Buy
7,978
+21
+0.3% +$5.18K 0.01% 310
2021
Q1
$1.54M Buy
7,957
+258
+3% +$50.1K 0.01% 317
2020
Q4
$1.64M Sell
7,699
-489
-6% -$104K 0.01% 271
2020
Q3
$1.4M Buy
8,188
+462
+6% +$79.2K 0.01% 251
2020
Q2
$1.48M Sell
7,726
-1,299
-14% -$249K 0.01% 231
2020
Q1
$1.33M Buy
9,025
+4,864
+117% +$716K 0.01% 207
2019
Q4
$645K Sell
4,161
-16
-0.4% -$2.48K ﹤0.01% 376
2019
Q3
$564K Buy
4,177
+161
+4% +$21.7K ﹤0.01% 365
2019
Q2
$490K Sell
4,016
-412
-9% -$50.3K ﹤0.01% 388
2019
Q1
$460K Buy
4,428
+48
+1% +$4.99K ﹤0.01% 375
2018
Q4
$499K Buy
+4,380
New +$499K 0.01% 348